6 Contents Market View: Equities cautious ahead of ECB Aer Lingus: Release traffic stats and announce positive union vote on IASS NOVEMBER 2014 Market View European equities opened lower, despite a record close in the S&P overnight A worsening European economy and signs Britain’s recovery has stumbled are hardening the stance of some Bank of England members, who want to keep the benchmark rate at a record-low 0.5 percent German Factory orders were lower this morning at 0.8% (survey 2.3%, prior -5.7%) Economic data will focus on the Bank of England Rates meeting at 12.00 and ECB Rates meeting at 12.45. Aer Lingus – (N/C) Previous Close €1.69 Following yesterday’s IMS Aer Lingus released October traffic stats this morning, showing continued growth in its long haul offering Short haul was 2.1% lower YoY, however long haul posted another strong performance, up 29% YoY Significantly, following the IMS, Aer Lingus also announced that it had received trade union support on the longstanding pension issue Comment: While load factors remained below low cost competitors at 79.6%, the company continues to improve this metric and total passengers carried was also up 2.3% YoY. The positive trade union ballot announced yesterday is an important step forward for the company and a resolution of the pension issue should remove a substantial overhang for the share price. The proposal must now receive shareholder approval and be put forward by the Pension trustee for approval by the Pension Authority. Should this occur it would be more good news for the flag carrier, which saw operating profit increase 19% to €112.9m in the last quarter. The company has sufficient free cash flow and cash on deposit to meet the proposed €191m pension obligation and any resolution would remove a significant liability on the balance sheet moving forward. The shares are trading on 13x FY15e earnings against the industry on 10x, however we would expect the airline to re-rate closer to peers once the pension issue is resolved. Siemens – (N/C) Previous Close €89.08 Siemens has released earnings this morning largely in line with consensus Revenues were up 1% YoY to €20.6bn but slightly below consensus of €20.68bn Q4 total sectors profit was €2.195bn, below consensus of €2.4bn Comments: Results are largely in line for Siemens with net income up to €1.44bn and EPS of €1.72 for the quarter. The company also confirmed the sale of its hearing aid unit for €2.2bn. We removed Siemens from the core portfolio noting geo-political concerns and the impact on-going sanctions in Russia would have on performance. The company has again reiterated this concern while discussing the outlook for 2015. Siemens sees EPS growth of 15% in 2015, however, given that they expect organic growth to be flat YoY the increase is likely to come from divestures of noncore businesses, like the sale of the hearing aid unit, announced today. We continue to like the restructuring story of Siemens but remain cautious given the potential impact of on-going geo-political tensions could have on earnings. The shares trade on 11.3x FY15e earnings a discount to peers on 14x. Siemens: Earnings in line IRISH PAPERS TODAY Ikea, Pepsi amongst 340 companies with secret Luxembourg tax deals (The Irish Times) Glanbia has paid over €1bn into Luxembourg companies to cut Irish tax bill (The Irish Independent) Tone of Trichet letter made it clear ECB was calling the shots for Ireland (The Irish Times) TH INTERNATIONAL PAPERS TODAY Republicans push for probusiness reform (Financial Times) AstraZeneca profits falls sharply (Wall Street Journal) Cameron loses support from EU allies (Financial Times) www.cantorfitzgerald.ie Equities Research Portfolio Management Bonds Regulatory Information This material is approved for distribution in Ireland by Cantor Fitzgerald Ireland Ltd. Cantor Fitzgerald Ireland Ltd (“CFIL”) is regulated by the Central Bank of Ireland. Cantor Fitzgerald Ireland Ltd is a member firm of the Irish Stock Exchange and the London Stock Exchange. Where CFIL wishes to make this and other Cantor Fitzgerald research available to Retail clients, such information is provided without liability and in accordance with our terms and conditions that are available on the CFIL website. 6th JUNE 2012 Buy Previous Close: €39.84 Price Target: €49.00 No report is intended to and does not constitute a personal recommendations or investment advice nor does it provide the sole basis for any evaluation of the securities that may be the subject matter of the report. Specifically, the information contained in this report should not be taken as an offer or solicitation of investment advice, or to encourage the purchased or sale of any particular security. Not all recommendations are necessarily suitable for all investors and CFIL recommend that specific advice should always be sought prior to investment, based on the particular circumstances of the investor either from your CFIL investment adviser or another investment adviser. CFIL takes all responsibility to ensure that reasonable efforts are made to present accurate information but CFIL gives no warranty or guarantee as to, and do not accept responsibility for, the correctness, completeness, timeliness or accuracy of the information provided or its transmission. This is entirely at the risk of the recipient of the report. Nor shall CFIL, its subsidiaries, affiliates or parent company or any of their employees, directors or agents, be liable to for any losses, damages, costs, claims, demands or expenses of any kind whatsoever, whether direct or indirect, suffered or incurred in consequence of any use of, or reliance upon, the information. Any person acting on the information contained in this report does so entirely at his or her own risk All estimates, views and opinions included in this research note constitute CANTOR IRELAND’s judgment as of the date of the note but may be subject to change without notice. Changes to assumptions may have a material impact on any recommendations made herein. Unless specifically indicated to the contrary this research note has not been disclosed to the covered issuer(s) in advance of publication. Past performance is not a reliable guide to future performance. The value of your investment may go down as well as up. Investments denominated in foreign currencies are subject to fluctuations in exchange rates, which may have an adverse affect on the value of the investments, sale proceeds, and on dividend or interest income. The income you get from your investment may go down as well as up. Figures quoted are estimates only; they are not a reliable guide to the future performance of this investment. Conflicts of Interest & Share Ownership Policy It is noted that research analysts' compensation is impacted upon by overall firm profitability and accordingly may be affected to some extent by revenues arising other CANTOR IRELAND business units including Fund Management and Stock broking. Revenues in these business units may derive in part from the recommendations or views in this report. Notwithstanding, CANTOR IRELAND is satisfied that the objectivity of views and recommendations contained in this note has not been compromised. Nonetheless CANTOR IRELAND is satisfied that the impartiality of research, views and recommendations remains assured. Our conflicts of interest management policy is available at the following link; http://www.cantorfitzgerald.ie/regulation_mifld.shtml Analyst Certification Each research analyst responsible for the content of this research note, in whole or in part, certifies that: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers; and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research note. US distribution This research note is being distributed by (CF Ireland / CF Europe / CF US / CF Canada / CF Hong Kong) in the United States and is intended for distribution in the United States solely to “major U.S. institutional investors” (as such term is defined in Rule15a-6 of the U.S. Securities Exchange Act of 1934 and applicable interpretations relating thereto) and is not intended for the use of any person or entity that is not a major institutional investor. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. It is prohibited for distribution to non-institutional clients including retail clients, private clients and individual investors. Major Institutional Investors receiving this research note should effect transactions in securities discussed in this research note through Cantor Fitzgerald & Co. This research note has been prepared in whole or in part by research analysts employed by non-US affiliates of Cantor Fitzgerald & Co that are not registered as broker-dealers in the United States. These non-US research analysts are not registered as associated persons of Cantor Fitzgerald & Co. and are not licensed or qualified as research analysts with FINRA or any other US regulatory authority and, accordingly, may not be subject (among other things) to FINRA’s restrictions regarding communications by a research analyst with a subject company, public appearances by research analysts, and trading securities held by a research analyst account. UK distribution This research note is approved for distribution in the United Kingdom by Cantor Fitzgerald Europe (“CFE”). CFE is authorised and regulated by the Financial Conduct Authority (“FCA”). While we believe this information and the materials upon which this information was based is accurate, except for any obligations under the rules of the FCA, we do not guarantee its accuracy. This material is only intended for use by eligible counterparties or professional clients who fall within articles 19 or 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2001 and not the general investing public. None of the investments or investment services mentioned or described herein are available to other persons in the U.K and in particular are not available to "retail clients” as defined by the rules of the FCA. Other important disclosures Prices quoted in this research note, unless otherwise indicated, are as of close on the previous trading day. The distribution of this research note in other jurisdictions may be restricted by law and persons into whose possession this specialist sales market commentary publication comes should inform themselves about and observe any such restrictions. By accepting this research note you agree to be bound by the foregoing instructions. Sources: CANTOR IRELAND Research, Bloomberg Dublin: 75 St. Stephen’s Green, Dublin 2, Ireland. Tel : +353 1 633 3800. Fax : +353 1 633 3856/+353 1 633 3857 CORK: Dolmen House, 45 South Mall, Cork. Tel: +353 21 422 2122. LIMERICK: Theatre Court, Lower Mallow Street, Limerick. Tel: +353 61 436500. www.cantorfitzgerald.ie Email : ireland@cantor.com web : www.cantorfitzgerald.ie Equities Research Portfolio Management Bonds